BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7105643)

  • 1. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G; Cazzani E; Romanò M; Muzio L
    Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)].
    Rouffy J
    Therapie; 1975; 30(6):815-23. PubMed ID: 785682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
    Passeri M; Cocchi C; Ceccato S; Palummeri E; Cucinotta D
    G Clin Med; 1979 Jan; 60(1):49-64. PubMed ID: 456778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thiadenol in the short-term treatment of patients with blood lipid disorders].
    Di Stefano F; Patane S; Gatto A
    Minerva Med; 1980 Mar; 71(8):567-74. PubMed ID: 7360386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antilipemic drugs].
    Schwandt P
    Med Monatsschr Pharm; 1980 Oct; 3(10):302-5. PubMed ID: 7007844
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].
    Cucinotta D; Palummeri E; Ceccato S; Passeri M
    G Ital Cardiol; 1977; 7(3):248-64. PubMed ID: 858465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on the antilipemic effect of tiadenol (Eulip)].
    Peduzzi L; Cozzi E
    Minerva Med; 1983 Feb; 74(6):249-54. PubMed ID: 6338419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate].
    Nicrosini F; Pasotti C
    Clin Ter; 1979 Aug; 90(3):241-50. PubMed ID: 553752
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dyslipoproteinemia of diabetes: fibrates or statins?].
    Moulin P
    Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drugs in hyperlipidemia].
    Stuyt PM
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1554-8. PubMed ID: 3670435
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tiadenol treatment of hyperlipoproteinemia in maturity onset diabetes].
    Vannini P; Ciavarella A; Motta R; Fiocchi M
    G Clin Med; 1980 Sep; 61(9):687-701. PubMed ID: 7009295
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
    Vailati G; Montini M; Simonutti M; Nosari I; Pagani G
    Clin Ter; 1978 May; 85(4):361-73. PubMed ID: 668273
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tiadenol in the treatment of primary hyperlipidemias].
    Liguori A; Sibilio G; Mastursi M; Tarzia R; Casale A; Pellegrino G; Varriale A
    G Clin Med; 1981 Jan; 62(1):51-64. PubMed ID: 7227710
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of tiadenol on type IIA hyperlipidemias].
    de Gennes JL; Truffert J; Le Quere JM
    Therapie; 1976; 31(4):455-63. PubMed ID: 188209
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
    Fodor JG; Frohlich JJ; Genest JJ; McPherson PR
    CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the antilipemic effect of etofibrate (Lipo-Merz)].
    Słowińska R; Bochenek W; Unlot J
    Pol Tyg Lek; 1983 Apr; 38(17):529-32. PubMed ID: 6356087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experimentation with a new drug lowering blood lipids (Tiadenol)].
    Potì R; Quintavalla R; Manotti C
    G Clin Med; 1977; 58(7-8):293-300. PubMed ID: 336442
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia].
    Colombo L; Monarca A; Goldberg D; Zanetta R
    Clin Ter; 1979 Oct; 91(2):155-71. PubMed ID: 540479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
    Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
    Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.